Markets article
*GRANULES INDIA LIMITED:* US SUBSIDIARY RECEIVES FDA EIR WITH NO ACTION INDICATED STATUS; SECOND INSPECTION CONCLUDED...
Publisher description: GRANULES INDIA LIMITED: US SUBSIDIARY RECEIVES FDA EIR WITH NO ACTION INDICATED STATUS; SECOND INSPECTION CONCLUDED WITH ZERO OBSERVATIONS; FACILITY PLAYS KEY ROLE IN OTC PRODUCT PACKAGING AND DISTRIBUTION. (POSITIVE FOR GRANULES)
telegram | Mar 5, 2026 | Kunvarji News Room